Once seen as a symptom, disrupted sleep is emerging as a modifiable driver of chronic illness. Drugmakers are targeting sleep pathways to reshape chronic disease biology, from pain to depression
Enjoying our latest content?
Log in or create an account to continue
- Access the most recent journalism from Nature’s award-winning team
- Explore the latest features & opinion covering groundbreaking research
Access through your institution
Sign in or create an account
Continue with Google
Continue with ORCiD
References
Thapa, R. et al. Nat. Med.32, 752–762 (2026)
Ramos, A. R., Wheaton, A. G. & Johnson, D. A. Prev. Chronic Dis.20, 230197 (2023)
Benjafield, A. V. et al. Sleep Med. Rev.82, 102121 (2025)
Jain, S. V. et al. Clin. Pract.14, 2650–2660 (2024)
Carette, S. et al. Arthritis Rheum.37, 32–40 (1994)
Kishi, T. et al. Transl. Psychiatry14, 374 (2024)
Author information
Authors and Affiliations
Science writer, Richmond, VA, USA
Carrie Arnold
Authors
- Carrie ArnoldView author publications
Search author on:PubMed Google Scholar
Rights and permissions
About this article
Cite this article
Arnold, C. Sleep as therapy.
Nat Med (2026). https://doi.org/10.1038/s41591-026-04582-5
Published:12 August 2026
Version of record:12 August 2026
DOI
:https://doi.org/10.1038/s41591-026-04582-5


